Aug 1, 2007

astrology cancer

Cancer Horoscope for week of January 18, 2007

Let me clarify your situation for you, Cancerian. Up until a short time ago, you'd been wandering through halls of mirrors, metaphorically speaking. Then you spied a hammer on the floor, got seized by a rash impulse, and proceeded to smash a lot of glass--again, metaphorically speaking. That was the first step to finding your way out of the labyrinth. Now you're ready for the next step: actually escaping. As you head out, I advise you to be careful that you don't cut yourself on all the shards. Liberation is near enough; there's no need to rush. Walk calmly and carefully towards the sound of the heartbeat you hear in the distance, metaphorically speaking.


You can still listen to my long-range, in-depth explorations of your destiny in 2007. Each report in the three-part series is about 6-8 minutes long. A new short-range forecast for this week is also available.

*

SACRED ADVERTISEMENT

Here's the catch about pronoia: Life always gives you exactly what you need, exactly when you need it, but it doesn't necessarily give you exactly what you want, exactly when you want it. Talk about the differences between what you want and what you need.

*


The preceding oracle comes from my book, PRONOIA Is the Antidote for Paranoia: How the Whole World Is Conspiring to Shower You with Blessings. It's available at Amazon or Barnes & Noble.

uterine cancer symptom

What is the uterus?

The uterus, also called the womb, is a hollow, pear-shaped organ located in a woman's lower abdomen, between the bladder and the rectum.

What are parts of the uterus?

  • cervix - the narrow, lower portion of the uterus

  • corpus - the broader, upper part of the uterus

    o myometrium - the outer layer of the corpus; the muscle that expands during pregnancy to hold the growing fetus

  • endometrium - the inner lining of the uterus

    What is uterine cancer?

    Cancers that occur in each part of the uterus have their own names, such as cervical cancer or endometrial cancer, but are sometimes broadly defined as uterine cancer because the structure is part of the uterus. Cancer of the uterus spreads through the bloodstream or lymphatic system, and is the most common cancer of the female reproductive tract.

    What are non-cancerous conditions of the uterus?

    Some conditions in the uterus, caused by abnormal, rapid, and uncontrolled division of cells, are not cancer. Three of these benign conditions include:

  • Fibroid tumors are common benign tumors of the uterine muscle that do not develop into cancer. Fibroid tumors of the uterus are very often found in women in their forties. And, although single fibroid tumors do occur, multiple tumors are more common.

    Symptoms of fibroid tumors, which depend on size and location, include irregular bleeding, vaginal discharge, and frequent urination. For fibroids that press against nearby organs and cause pain, surgery may be necessary. Many times, however, fibroids do not cause symptoms and do not need to be treated. After menstrual periods cease, fibroid tumors may become smaller and may disappear altogether.

  • Endometriosis is a benign condition of the uterus that is common among women in their thirties and forties, especially women who have never been pregnant. Tissue that looks and acts like endometrial tissue begins to grow in unusual places, such as on the surface of the ovaries, on the outside of the uterus, and in other tissues in the abdomen.

  • Hyperplasia is an increase in the number of normal cells lining the uterus. Although it is not cancer, it may develop into cancer in some women. The most common symptoms are heavy menstrual periods, bleeding between periods, and bleeding after menopause.

    What are risk factors for uterine cancer?

    The following have been suggested as risk factors for uterine cancer:

  • age 50 or over

  • history of endometrial hyperplasia

  • estrogen replacement therapy (ERT)

  • being overweight

  • diabetes

  • hypertension (high blood pressure)

  • history of other cancers

  • history of taking tamoxifen for breast cancer treatment or prevention

  • Caucasian women

    What are the symptoms of uterine cancer?

    According to the National Cancer Institute, abnormal bleeding after menopause is the most common symptom of cancer of the uterus. Other symptoms, according to the National Cancer Institute, may include:

  • unusual vaginal bleeding or discharge

  • difficult or painful urination

  • pain during sexual intercourse

  • pain in the pelvic area Cancer of the uterus often does not occur before menopause. It usually occurs around the time menopause begins. The occasional reappearance of bleeding should not be considered simply part of menopause. It should always be checked by a physician.

  • cancer society

    The creation of the ULTRAVIOLET clothing range came about from first hand experience of cancer in the close knit family of Marilyn Seyb. The range aims to increase awareness of being safe in the sun while being covered with long sleeved garments and trousers that optimise the effect of layering:-

    Visit a Kimberleys store to view the fantastic range.

    As a result of this association, Kimberleys are also contributing a significant annual donation to the Cancer Society for at least the next three years.

    The Cancer Society wishes to thank Marilyn and John for their foresight and contribution.

    Cancer will affect one in every three New Zealanders at some stage du ring their lives.


    The Cancer Society Auckland is here to provide support to cancer patients and their families, to prevent the onset of cancer, and to carry out scientific research into cancer.



    We rely solely on the generosity of the public of Auckland and Northland for financial and volunteer support in order to provide these services. We do not accept direct Government funding as we do not wish to be compromised in any advocacy or lobbying we undertake.


    We have been serving the communities of Auckland and Northland for 75 years and intend to go on meeting the needs of cancer patients and their families.







    RESEARCH CENTRE ON TV ONE 'SUNDAY' PROGRAMME 13 NOVEMBER 2006.

    Click here to view the article on Auckland Cancer Society Research Centre's latest drug development on TVNZ site.



    AWARDS TO OUR RESEARCHERS

    Congratulations to Professor Bruce Baguley on being awarded the 2006 Sir Charles Hercus Medal of the Royal Society of New Zealand. This is awarded biennially in rotation in three different areas of biomedical and health sciences. Professor Baguley receives the 2006 medal for his contribution towards the advancement of the molecular and cellular sciences and technologies in New Zealand.

    Professor Bill Denny is the 2006 recipient of the Adrien Albert award of the Royal Australian Chemical Institute. This is the premier award of the Biomolecular Chemistry Division, and is given for “sustained, outstanding research in any field related to biomolecular chemistry and conducted wholly, or largely, within Australia and New Zealand”.


    The Peter Gluckman Medal for 2006 has been jointly awarded to Professor Bruce Baguley and Professor Bill Denny. The award is presented to acknowledge the enormous dedication these researchers share and the subsequent contributions both have made in the field of cancer research and drug development. The award is intended to recognise distinguished contributions of current and former staff or students of the Faculty of Medical and Health Sciences. Fittingly, it has become the Faculty’s premier acknowledgement of research endeavours and just as fittingly in 2006, it is being shared. by two world class research scientists.

    lymph node cancer

    Secondary cancer in the lymph nodes

    This information is about secondary cancer in the lymph nodes. This describes the situation where cancer cells have spread to the lymph nodes from a cancer that began elsewhere in the body.

  • The lymphatic system

  • Cancer in the lymph nodes

  • How cancers can spread

  • Signs and symptoms

  • How it is diagnosed

  • Treatment

  • Your feelings

  • References

    A lymph node biopsy removes lymph node tissue to be looked at under a microscope for signs of infection or a disease, such as cancer. Other tests may also be used to check the lymph tissue sample, including a culture, genetic tests, or tests to study the body's immune system (immunological tests).

    Lymph nodes are part of the immune system. They are found in the neck, behind the ears, in the armpits, and in the groin. See an illustration of lymph nodes and the immune system。

    Lymph nodes in healthy people are usually hard to feel. However, lymph nodes in the neck, armpit, or groin can get bigger and become tender. Swollen lymph nodes usually mean an infection, but the swelling can also be caused by a cut, scratch, tattoo, a drug reaction, or cancer.

    There are several ways to do a lymph node biopsy. The lymph node sample will be looked at under a microscope for problems.

  • A fine-needle aspiration biopsy puts a thin needle into the lymph node and removes cells to look at. A needle biopsy is done to check the cause of a big lymph node.

  • A core needle biopsy uses a needle fitted with a special tip. The needle goes through the skin to the lymph node to take a sample of tissue about the size of a pencil lead.

  • An open biopsy makes a cut in the skin and removes the lymph node. If more than one lymph node is taken, the biopsy is called a lymph node dissection. Open biopsy and lymph node dissection let your doctor take a bigger sample than a needle biopsy.

    Why It Is Done

    Lymph node biopsy is done to:

  • Check the cause of big lymph nodes that do not go away.

  • Check the cause of symptoms, such as an ongoing fever, night sweats, or weight loss.

  • Check to see if a known cancer has spread to the lymph nodes. This is called staging and is done to plan cancer treatment.

  • Remove cancer.
  • cancer bracelet

    Cancer Awareness Bracelet Features

  • Sterling Silver Alphabet beads engraved on all four sides

  • .925 Bali Silver spacers and Sterling Silver beads

  • Choice of Sterling Silver clasps

  • Optional Swarovski Crystals, the highest quality crystals available

  • Crystal color choices based upon American Cancer Society designations

    o Brain Cancer - Gray

    o Breast Cancer - Pink

    o Childhood Cancer - Amber

    o Colon Cancer - Royal Blue

    o Colorectal Cancer - Brown

    o Leukemia - Orange

    o Lung Cancer - Clear

    o Melanoma - Black

    o Ovarian, Cervical, Uterine Cancer - Teal

    o Pancreatic Cancer - Purple

    o Prostate Cancer - Light Blue

    o Other Cancers - Lavender

  • A portion of the proceeds from the sale of each Cancer Bracelet is donated to the American Cancer Society

  • Free Shipping - Quick Delivery

    All of these features combined with attention to detail come together in creating your Personalized Cancer Bracelet, a Bracelet of lasting beauty.

    Pink Silicone Breast Cancer Bracelets

    This is a very popular pink silicone breast cancer bracelet. It has the words Hope, Faith, Courage and Strength. Awareness ribbons sit between each word. The wristband comes in two sizes: Adult 8" and Youth 7".


    Shanrene, Inc. has partnered with the National Breast Cancer Coalition. For each breast cancer wristband sold, Shanrene donates $.25 directly to the NBCCF! Your purchase of this pink silicone breast cancer bracelet will benefit charity!

  • early symptom of lung cancer

    Early Symptoms of Lung Cancer

    Common signs and symptoms of lung cancer include:

  • A cough that doesn't go away and gets worse over time

  • Constant chest pain

  • Coughing up blood

  • Shortness of breath, wheezing, or hoarseness

  • Repeated problems with pneumonia or bronchitis

  • Swelling of the neck and face Loss of appetite or weight loss

  • Fatigue

    These symptoms may be caused by lung cancer or by other conditions. It is important to check with a doctor.

    The symptoms of lung cancer frequently go unrecognised in the early stages of the disease, experts say.

    Lung cancer typically makes itself known through coughing, breathlessness and weight loss, said Professor Dieter Koehler, president of the German Society for Pneumology and Respiratory Medicine in Werne, North Rhine Westphalia.

    Further symptoms are pains in the chest and swollen fingertips, the so-called clubbed finger.


    An X-ray, an endoscopic examination of the lungs or an analysis of the mucus the patient coughs up are ways of determining whether the patient has lung cancer, said Michael Barczok of the German Federal Association of Pneumologists in Heideheim.


    People at greatest risk of lung cancer are current and former smokers, as well as people whose relatives have already developed lung cancer or chronic obstructive lung diseases, experts say. The risk of getting a bronchial cancer is two to three times greater among people who have a biological relative who had lung cancer, Koehler said.


    The disease usually begins at a younger age among people with a genetic disposition, according to Koehler.


    "They become ill at age 50 as opposed to age 70," he said.


    The earlier the disease is detected, the better the survival rate. Only 15 percent of the people age 70 or older who are diagnosed with the disease are still alive five years later. Lung cancer is the cause of death for more than 40,000 people annually in Germany, making it one of the most common malignancies.

  • bladder cancer symptom

    The symptoms for bladder cancer are not specific. Many other diseases, including inflammatory conditions, involving the bladder and kidney may cause similar symptoms. However, since early detection is important in curing bladder cancer, if you have these symptoms, you should bring them to the attention of your doctor.

    The most common first symptom of bladder cancer is blood in the urine called hematuria. Hematuria is either visible or microscopic.

    o Gross hematuria describes urine that appears red or brown and can be seen with the naked eye

    o Microscopic hematuria means the red blood cells are visible if a urine sample is examined under a microscope

    Irritative urination symptoms may also be associated with bladder cancer and include:

    o pain and burning on urination,

    o a sense of incomplete emptying of the bladder after urination and

    o having to urinate more frequently or at shorter intervals.

    The symptoms above could also indicate problems (less serious) other than bladder cancer.

    Bladder Cancer Symptoms

    Bladder cancer is common disease in the United States. Research tells us that it occurs mainly in industrialized countries, such as the US, France, and Canada.


    Bladder cancer symptoms are few, yet very noticeable. Bladder cancer symptoms include:



  • Blood in the urine: The presence of blood in urine, is called hematuria. Blood can either be seen by the eye, in which it is called gross hematuria. Blood can also be seen under a microscope, and it is then called microscopic hematuria.

  • Pain during urination: Pain during urination is called dysuria. Pain can range from mild to severe.



  • Frequent urination: Having to urinate often and during the night is also a symptom.



  • sign of colon cancer

    With proper screening, colon cancer should be detected BEFORE the development of symptoms, when it is most curable.

    Most cases of colon cancer have no symptoms. The following symptoms, however, may indicate colon cancer:

    · Diarrhea, constipation, or other change in bowel habits that does not resolve

    · Blood in the stool

    · Unexplained anemia (anemia in any adults other than menstruating women should almost always be evaluated by a colonoscopy)

    · Abdominal pain and tenderness in the lower abdomen

    · Intestinal obstruction

    · Weight loss with no known reason

    · Stools narrower than usual

    Some citations in the text of this section are followed by a level of evidence. The PDQ editorial boards use a formal ranking system to help the reader judge the strength of evidence linked to the reported results of a therapeutic strategy. Refer to the PDQ levels of evidence summary for more information.

    Cancer of the colon is a highly treatable and often curable disease when localized to the bowel. It is the second most frequently diagnosed malignancy in the United States as well as the second most common cause of cancer death. Surgery is the primary treatment and results in cure in approximately 50% of patients. Recurrence following surgery is a major problem and often is the ultimate cause of death. The prognosis of colon cancer is clearly related to the degree of penetration of the tumor through the bowel wall and the presence or absence of nodal involvement. These 2 characteristics form the basis for all staging systems developed for this disease. Bowel obstruction and bowel perforation are indicators of poor prognosis. Elevated pretreatment serum levels of carcinoembryonic antigen (CEA) have a negative prognostic significance. Many other prognostic markers have been evaluated retrospectively in the prognosis of patients with colon cancer, although most have not been prospectively validated. Age greater than 65 years at presentation is not a contraindication to standard therapies; acceptable morbidity and mortality, as well as long-term survival, are achieved in this patient population.

    Because of the frequency of the disease, the identification of high-risk groups, the demonstrated slow growth of primary lesions, the better survival of early-stage lesions, and the relative simplicity and accuracy of screening tests, screening for colon cancer should be a part of routine care for all adults starting at age 50 years, especially for those with first-degree relatives with colorectal cancer. There are groups that have a high incidence of colorectal cancer. These groups include those with hereditary conditions, such as familial polyposis, hereditary nonpolyposis colon cancer (HNPCC), Lynch I Syndrome, Lynch II Syndrome, and ulcerative colitis. Together they account for 10% to 15% of colorectal cancers. Patients with HNPCC reportedly have better prognoses in stage-stratified survival analysis than patients with sporadic colorectal cancer, but the retrospective nature of the studies and possibility of selection factors make this observation difficult to interpret.[Level of evidence: 3iiiA] More common conditions with an increased risk include: a personal history of colorectal cancer or adenomas, first degree family history of colorectal cancer or adenomas, and a personal history of ovarian, endometrial, or breast cancer.These high-risk groups account for only 23% of all colorectal cancers. Limiting screening or early cancer detection to only these high-risk groups would miss the majority of colorectal cancers.For more information on this subject, consult the PDQ summaries on screening for colorectal cancer and prevention of colorectal cancer. Following treatment of colon cancer, periodic evaluations may lead to the earlier identification and management of recurrent disease.The impact of such monitoring on overall mortality of patients with recurrent colon cancer is limited by the relatively small proportion of patients in whom localized, potentially curable metastases are found. To date, there have been no large-scale randomized trials documenting the efficacy of a standard, postoperative monitoring program. Postoperative monitoring may detect asymptomatic recurrences that can be resected or metachronous tumors.CEA is a serum glycoprotein frequently used in the management of patients with colon cancer. A review of the use of this tumor marker suggests: that CEA is not a valuable screening test for colorectal cancer due to the large numbers of false-positive and false-negative reports; that postoperative CEA testing be restricted to patients who would be candidates for resection of liver or lung metastases; and that routine use of CEA alone for monitoring response to treatment not be recommended. However, the optimal regimen and frequency of follow-up examinations are not well defined, since the impact on patient survival is not clear.

    blood cancer

    It is unacceptable that blood cancers are considered incurable.

    Research in finding more effective treatments and cures for blood cancers is proceeding at an extrordinary and positive pcae. In my laboratory at the Moores UCSD Cancer Center - which leads the nation in blood cancer research - we are pursuing many innovative approaches. We constantly increasing our understanding of the genetics, immune resposnse, and diet on the course of cancer. We're not only involved in the discovery of genes involved in blood cancer, but also determinig how thoses genes affect the overall progress of blood cancers.

    To continue with this rapid pace of research and discovery, I need to recruit more of the talented scientist in the world to join our team at the Moores UCSD Cancer Center. The key to our success lies in the ability to explore every potential avenue to a cure. Simply put, the more scientists we can train, attract, and support to assist in the research process, the sooner we will find the treatments that will control cancer. Our research is not confined to the laborartory, in the unique setting of the Moores UCSD Cancer Center, we are helping cancer patients everyday. Our goal is to serve patient from the laboratory bench to there bedside. In today's world of limited governmental resources, to sustain our progress we need to ask for your help! Only your gifts will allow us to accelerate the pace of our research leading to a cure in our lifetime. Without your help too many people with cancer will not be saved; too many families will needlessly suffer the loss of a loved one.

    bone cancer symptom

    Bone Cancer is the most common malignant growth that occurs in bone results from cancer that has spread from other parts of the body - secondary bone cancer. Bone cancer can be extremely painful and frightening for the children and adults that it strikes. Cancer that arises in the bone itself is primary bone cancer. All forms are rare. The best bone cancer treatments combine several types of therapies. For example, our surgeons, oncologists, and radiation therapists work together to improve the success rates of bone cancer surgery by using chemotherapy treatments prior to surgery.

    The most common forms of primary bone cancer are:

    1. Osteosarcoma , which occurs primarily in growing bone tissue. Osteosarcoma also called osteogenic sarcoma, arises in bone-forming cells. It can occur at any age but is most common between 10 and 20. Any bone can be affected, but more than half of all osteosarcomas develop around the knee. Osteosarcoma causes a painful swelling of the affected bone.

    2. Chondrosarcoma , which occurs in cartilage. Chondrosarcoma usually develops in middle age, and the tumour grows slowly in the early stages. Later it may spread to nearby soft tissues and to other parts of the body. The diagnosis can only be made by biopsy, and treatment is by surgical removal of the tumour. In some cases, amputa-tion of the bone above the tumour is advised to improve the chance of cure.

    3. Ewing's sarcoma , which arises primarily in immature tissue in bone marrow. If Ewing's sarcoma is suspected from its X-ray appearance and confirmed by biopsy, CAT and radionuclide scanning of the whole body is advised to discove whether, and how far, the cancer has spread Treatment is with a combination of chemotherapy and radiotherapy, and sometimes by surgery. There is a good chance of cure if the diagnosis is early.

    Depending on the type of cancer you have and whether it has spread, your doctor may use chemotherapy to:

    · Eliminate all cancer cells in your body, even when cancer is widespread

    · Prolong your life by controlling cancer growth and spread

    · Relieve symptoms and enhance your quality of life

    Symptoms of Bone Cancer

    Here is the list of some of the common sign and symptoms of bone cancer :

    · Weakened bones, sometimes leading to fractures

    · Joint swelling and tenderness (for tumors in or near joints)

    · Fatigue

    · Fever

    · Weight loss

    · Anemia

    In a few cases, bone cancers may have a hereditary component, such as in:

    · Li-Fraumeni syndrome. This condition is characterized by an increased risk of many different cancers, including osteosarcoma, leukemia, breast cancer, ovarian cancer and others.

    · Rothmund-Thomson syndrome. This condition causes short stature, skeletal problems and rashes, and increases risk of bone cancer.

    · Hereditary retinoblastoma. Children with this rare cancer of the eye have an increased risk of osteosarcoma. · Multiple exostoses. Children with this inherited condition that causes cartilage bumps to form on your bones have an increased risk of chondrosarcoma.

    cancer clinic

    The Columbus Cancer Clinic provides helping hands to the community, assisting those affected by cancer and those wishing to be screened. It is a non-profit United Way agency that has served the greater Columbus area since 1921. The Clinic educates the public about cancer prevention and the benefits of early detection; offers affordable, accessable screening examinations, mammograms and tests; and provides home care support services. All clients can receive needed services, regardless of ability to pay.

    As of May 1, 2005, the Columbus Cancer Clinic is provided by LifeCare Alliance, a local United Way agency founded in 1898 by the Columbus Cancer Clinic’s founder, Carrie Nelson Black. The name will continue to be Columbus Cancer Clinic and no program or staff changes are planned. The Clinic will continue to operate from its Clintonville location at 65 Ceramic Drive. For more information about LifeCare Alliance, visit www.lifecarealliance.org.

    Celebrating almost 50 years of treating patients with tumors and cancer of the Head and Neck.

    Head and Neck Cancer, Tumor Information

  • Oral Cancer

  • Lip Cancer

  • Tongue Cancer

  • Squamous Cell Cancer of the Oral Tongue

  • Squamous Cell Cancer of the Base of Tongue

  • Voice Box Cancer

  • True Cord Cancer

  • Subglottic Squamous Cell Cancer

  • Medical Director Information or related links to websites with more information on oral cancer, throat cancer, tongue cancer, lip, larynx, tongue, oral cavity, oropharynx, paranasal sinuses, cervical esophagus, neural tumors, carotid body tumors, melanoma, and reconstruction needs.

  • cancer information

    Pulmonary metastatic soft tissue sarcoma curable with surgical excision

    Reuters Health Posting Date: January 19, 2007

    Last Updated: 2007-01-19 14:13:32 -0400 (Reuters Health) NEW YORK (Reuters Health) - Resection of soft tissue sarcoma metastatic to the lungs can be accomplished with very low morbidity and mortality, surgeons in Germany report, and may in fact be curative. Although pulmonary soft tissue sarcomas (STS) resection is a common procedure, lead author Dr. Alexander Rehders and his associates note in the Archives of Surgery for January, agreement as to which patients make the best candidates has yet to be established. Their current results suggest that "it seems worthwhile to operate on every patient with lung metastasis unless serious comorbidity or technically unresectable metastatic disease is present." At University Hospital in Hamburg-Eppendorf, all patients with operable lung STS metastasis undergo radical surgery with curative intent. The only exceptions are failure of the primary tumor to regress at least partially after 6 months of chemotherapy, extensive involvement of the mediastinum or chest wall, unresectable lung disease or metastatic disease outside the lung, other comorbidities, or insufficient pulmonary function. Between 1991 and 2002, 61 of 121 patients at their institution who developed pulmonary metastasis of STS underwent sternotomy or anterior lateral thoracotomy for metastasectomy, including wedge resection or lobectomy. There were no cases of perioperative mortality. Nine patients experienced transient alveolar leakage requiring pleural drainage, three had wound infections, and three experienced hypoventilation. Otherwise, there were no major complications. After a mean follow-up of 60 months, survival time averaged 33 months (range 2 to 125 months), the authors report. The 5-year survival rate was 25%. None of the common risk factors assessed - age, gender, tumor grade, number of metastatic lesions, bilateral involvement, histologic type, site of primary tumor, and interval before STS metastasis was diagnosed - had any significant effect on survival. Dr. Rehders and his associates report that six patients underwent repeat STS excisions, and that these patients were among the 13 who lived the longest. Arch Surg 2007;142:70-75. Copyright ? 2006 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

    cancer prevention

    Since passage of the 1971 National Cancer Act, the overall incidence of cancer in the U.S. has escalated to epidemic proportions, now striking 1.3 million, and killing about 550,000 annually. The median age for the diagnosis of cancer is adults, and six in children

    Tobacco and Cancer



    Smoking damages nearly every organ in the human body, is linked to at least 10 different cancers, and accounts for some 30% of all cancer deaths. And it costs billions of dollars each year. Yet one in four Americans still light up. If you or someone you love uses tobacco, here's what you need to know about how tobacco kills, and how to get the help you need to quit. function tobaccoNews()

    Sun Safety



    A sunburn will fade, but damage to deeper layers of skin remains and can eventually cause cancer. That's why sun-safe habits should begin in childhood and last a lifetime.


    Food and Fitness Eating right, being active, and maintaining a healthy weight are important ways to reduce your risk of cancer-as well as heart disease and diabetes. Learn the American Cancer Society's guidelines for diet and activity and find tips for a healthy lifestyle and community.


    Environmental Carcinogens



    Environmental factors can include smoking, diet, sun exposure, and infectious diseases, as well as chemicals and radiation in our homes and workplaces. Learn more about these risks and how you can reduce them.


    Environmental Carcinogens


    Environmental factors can include smoking, diet, sun exposure, and infectious diseases, as well as chemicals and radiation in our homes and workplaces. Learn more about these risks and how you can reduce them.

    metastatic breast cancer

    Recurrent and Metastatic Breast Cancer

    We know you really don't want to be here, reading about breast cancer recurrence or metastasis. If you've had breast cancer, the possibility of recurrence and spread (metastasis) of breast cancer stays with you. You may be here because you fear this possibility. Or you may be here because it's already happened.

    Keep in mind that a recurrence of breast cancer or metastatic (advanced) disease is NOT hopeless. Many women continue to live long, productive lives with breast cancer in this stage. It is also likely that your experience with treatment this time will be somewhat different from last time. There are so many options for your care and so many ways to chart your progress as you move through diagnosis, treatment, and beyond.

    Because there are so many options, this is a long section. You may want to read just a few pages at a time. You might find it very difficult to concentrate, think straight, and remember what you've read. That's natural when you're anxious, uncertain, overwhelmed. We'll do our best to help you find what you're looking for.

    If you're already feeling stuck in the fear and you need to deal with that first, here are a few places to try right away:

    · Start with the TALK BACK TO FEAR button, to find some comfort as well as logical answers for your fears.

    · Then read about coping with fear of recurrence · Also visit the discussion boards and chat rooms, where other women who've been there are ready to reach out and help you get through the whole experience.

    cancer stage

    Improved ways to access and analyse stored medical data for the staging of lung cancer patients

    Much of the current global information explosion is due to the emergence of new digital technologies for acquiring and storing medical data. This is especially true in the health domain; in particular, new digital medical imaging systems are emerging with increasing resolution and new enterprise-wide information systems are accumulating vast amounts of both structured and unstructured medical data. While the richness of this data brings a range of potential benefits to the health system, often these can be overwhelmed by the burden of processing such sheer volumes of data.

    Multimedia Content Analysis (MCA)

    MCA is a field of research that facilitates the management and interpretation of large amounts of multimedia data, encompassing text, image, audio and video, as well as traditional structured databases. The field draws on diverse research areas, including sensor technologies, signal processing, pattern recognition, machine learning, information retrieval and human computer interaction.

    Research Focus

    The CSIS project builds upon a core research capability in multimedia content analysis within the health domain, focusing on a particular application: support systems for cancer management, both for individual patients and population-level analyses.

    The cancer "stage" is a categorisation of its progression in the body, in terms of the extent of the primary tumour and any spreading to local or distant body sites. While staging has a fundamental role in cancer management, due to the expertise and time required and the multi-disciplinary nature of the task, cancer patients are not always routinely staged. By automating the collation, analysis, summarisation and classification of relevant patient data, the reliance on expert clinical staff can be lessened, improving the efficiency and availability of cancer staging.

    Initial work will investigate the summarisation and categorisation of patient reports to assist with staging lung cancer. Longer term research will investigate extending this in three ways:

    § Extensions to handle other data and cancer types. Initial work is focusing on staging lung cancer using text reports radiology, histology), however opportunities exist to extend this to bowel and other cancers, and also to use information extracted from other forms of data, for example, radiological images.

    § Classifying cancer characteristics other than stage. The techniques used to classify cancer stage may be extended to other tasks, such as filtering of patient data, for example, screening for cancer / non-cancer, or classification of cancer types.

    § Population-level analyses. Statistical models may be used to identify trends and anomalies in cancer patient demographics or treatment / response characteristics, based on metadata extracted through the automatic content analysis techniques (for example, cancer type, cancer stage, etc). The CSIS project will produce engineered software prototypes and evaluate these in appropriate proof-of-concept and clinical user trials.

    asbestos cancer

    For your convenience, we have consolidated mesothelioma treatment information for your review. This section is updated on a weekly basis to cover the latest on conventional treatments, experimental treatments and ongoing clinical trials.

    Asbestosis

    Asbestosis is a non-cancerous, chronic lung illness caused by exposure to asbestos.

    Significant exposure to asbestos increases the risk of lung cancer, mesothelioma and non-malignant lung and pleural disorders.

    Risk depends on duration, frequency, concentration, & type of asbestos fibres.

    Diseases from asbestos exposure take a long time to develop. Most cases of asbestosis occur in asbestos workers 15 or more years after initial exposure to asbestos.

    Smoking greatly increases the likelihood of lung cancer in workers exposed to asbestos (although smoking does not appear to increase the risk of mesothelioma).

    Mesothelioma (asbestos cancer)

    Mesothelioma is a rare cancer which may affect the lining of the lungs (pleura) and the abdominal cavity (peritoneum).

    Most mesotheliomas are caused by exposure to asbestos.

    Most cases of mesothelioma are diagnosed 30 years or more after the first exposure to asbestos.

    Mesothelioma occurs more often in men than in women.

    Risk increases with age.

    Symptoms & Signs

    Shortness of breath (this is the primary symptom)

    A persistent and productive cough

    Chest tightness

    Chest pain

    Loss of appetite/weight loss

    A crackling sound in the lungs while inhaling.

    Diagnosis

    History of asbestos exposure.

    Chest X-rays are the most common method of detecting asbestos-related disorders.

    Other tests:

    Physical Examination

    Pulmonary Function Tests

    Biiopsy/Bronchoscopy CT scan

    breast cancer bracelet

    IBC typically cannot be identified through:

    Mammogram – Because IBC usually does not occur in the form of a lump (the cancer is spread throughout breast tissue), it is difficult to detect with a mammogram. The most characteristic mammography findings consist of swelling of the skin.

    Ultrasound – This test confirms the swelling (edema) of the skin and can better identify breast nodules (if present). It also is the most appropriate test for the evaluation of lymph nodes.

    Magnetic Resonance Imaging (MRI) – This is probably the most sensitive test because it includes a functional description of the abnormal findings. It should be included among the diagnostic tests once the pathological diagnosis is confirmed. It is extremely useful in evaluating the clinical response to chemotherapy.

    Core biopsy – Typically, fine-needle aspiration or a core biopsy (removal of tissue with a needle) is performed to obtain a pathological diagnosis of invasive disease, but these diagnostic procedures are not appropriate for IBC because of the peculiar growth pattern in the breast lymphatic system.



    What diagnostic tests identify IBC?

    Surgical biopsy – Most of the time a skin biopsy or a surgical biopsy is necessary. These procedures are able to collect larger samples that include the skin and underlying tissue with higher chances to identify the cancer cells.

    PET Scan – In the near future, this could be one of the most important diagnostic/staging tests for IBC, though it still is under study. We have found that with the PET scan we can see more disease.



    We can see lymph nodes far from the breast, which tells us we have a metastatic cancer already at the time of diagnosis. If we limit staging to mammogram, CT (computed tomography – computerized X-rays) and bone scans we may miss different components of this inflammatory spreading, which may have significant consequences in the way we treat the cancer and the way we process patients.



    What is the survival rate for IBC?

    The five-year median survival rate for inflammatory breast cancer is approximately 40%. The main reasons for such a disappointing outcome are multiple and include: a delay in diagnosis, the lack of expertise in treating IBC because it is so rare and the relative resistance the disease has to standard chemotherapeutic agents.



    With regard to the first critical issue, it is important to keep in mind that IBC is a fast-growing cancer (it can spread within weeks), and it is often mistaken for something other than breast cancer, such as a rash or infection.

    cancer picture

    Inflammatory breast cancer is a unique and uncommon type of breast cancer. It is unique in that inflammatory breast cancer does not produce a distinct mass or lump that can be felt within the breast. The lack of a lump or mass also makes inflammatory breast cancer difficult to detect by mammograms. Inflammatory breast cancer cells infiltrate the skin and lymph vessels of the breast. When the lymph vessels become blocked by the breast cancer cells the breast typically becomes red, swollen, and warm. The skin changes associated with inflammatory can cause the breast skin to look like the skin of an orange a finding called peau d'orange. The appearance of the breast is similar to other inflammatory conditions such as cellulitis or mastitis. Other possible associate symptoms include enlarged lymph nodes under the arm or above the collar bone on the affected side.



    Inflammatory breast cancer is diagnosed based upon the results of a biopsy and the clinical judgment of the treating physician. Typically, inflammatory breast cancer grows rapidly and requires aggressive treatment. There are two aspects to treating all breast cancer, local treatment and systemic or total body treatment. Because inflammatory breast cancer is aggressive, most oncologists recommend both systemic and local treatment. The typical sequence of treatment is to start with chemotherapy, systemic treatment, followed by surgery and radiation therapy, which are the local treatments, often followed by additional chemotherapy and possibly hormone treatments. With aggressive treatment using this multimodality approach, the 5 year survival for inflammatory breast cancer has improved significantly from an average survival of 18 months to an approximately 50% survival rate at 5 years.



    How many cases of IBC are diagnosed each year?

    The numbers vary, but approximately 1% to 2% of newly diagnosed invasive breast cancers (that have spread beyond the breast) in the United States are described as inflammatory breast cancers.

    beating cancer with nutrition

    "I'm sorry, but you have cancer." These words from a doctor introduce fear into the heart of any patient.

    The good news is that supportive nutrition therapy can significantly increase cancer patients' quality and length of life and improve their chances for a complete remission. Better yet, a healthy lifestyle that includes a wholesome diet, sufficient exercise, positive attitude and toxin avoidance can prevent up to 90 percent of cancers.

    Now for the bad news. Conventional medicine does not have a high success rate with the disease. By the turn of this century, cancer will become the leading cause of death in America. During the past 26 years, NCI spent $37 billion in research with a resulting increase in cancer incidence and deaths. Clearly, medicine cannot produce a "magic bullet" to cure cancer while patients go on living on soft drinks, pollutants and stress.

    On December 23, 1971, President Richard M. Nixon confidently declared a "war on cancer" and promised a cure by the 1976 Bicentennial. However, as late as 1991, a group of 60 noted physicians and scientists called a press conference and made the following statement: "The cancer establishment confuses the public with repeated claims that we are winning the war on cancer. ... Our ability to treat and cure most cancers has not materially improved." this article, I will briefly explore the reasons for failure in combating cancer and give rational directions to improve outcomes for the 2.5 million cancer patients being treated in America today.

    Developing A Strategy

    In early research, the techniques of surgery, radiation and chemotherapy looked like the best approaches to cancer. The goal was to cut away, burn and poison the abnormal cells. While such therapies can temporarily reduce tumor burden, they do not cure cancer. Only by changing the underlying cause of the disease can a cancer patient expect to return to health.

    Doctors now know that eliminating cancer begins with changing the conditions that support tumor growth, not just applying cytotoxic therapies to kill cancer cells. Here's an analogy: Fungus grows on the bark of a tree due to the favorable conditions of heat, moisture and darkness. You can cut, burn and poison a fungus all you want, but as long as favorable conditions persist, it will flourish. Similarly, cancer develops in a human when conditions are right. Documented factors that favor tumor formation include toxic burden, immune suppression, malnutrition, mental depression and elevated blood glucose. More speculative causative factors include reduced pH, dysbiosis (abnormal bacteria in the gut), hypothyroidism, insufficient gland and organ output (i.e., insufficient DHEA, enzymes and hydrochloric acid) and parasites. Unless we correct these cancer inducers, cytotoxic therapies are doomed to failure.

    The best way to correct the problem is through therapeutic use of nutrients. But, as a word of caution, while nutrition should be an integral component of every cancer patient's treatment program, nutrition therapy alone is probably insufficient for most advanced cancers. The reasons for using therapeutic nutrition in cancer treatment are numerous and include the following:

    * Malnutrition: Undernourishing your body can have devastating, even fatal consequences. In fact, more than 40 percent of cancer patients die from malnutrition, not the cancer itself.2 Cancer induces a metabolic abnormality akin to getting your car stuck on ice--the wheels spin and the engine guzzles gas, but you don't go anywhere. Yet, cancer patients often eat less food than they did before their illness began. One reason is that tumors induce a hypermetabolic state and secrete a substance called cachectin that suppresses appetite. Chemo and radiation therapy can also cause anorexia and alone are sufficient biological stressors to induce malnutrition.3 Because cancer patients need more calories than healthy people, they eventually waste away, a condition called cachexia. Weight loss increases the mortality rate for most types of cancer, while also lowering the positive response to chemotherapy.4 In addition to proper eating, nutrient-dense "shakes," canned nutritional formulas, protein powders, hydrazine sulfate, enzymes, DNA loading and other therapies can reverse the weight loss that consumes far too many cancer patients. If cancer patients lose 10 percent or more of their body weight after cancer diagnosis, all other nutrition strategies are irrelevant until this problem is addressed. A word of caution: Do not fill up a fragile stomach with vitamin pills when nutrient-dense foods are more important.

    liver cancer treatment

    Physicians Stop Liver Cancer with Millions of Glass Beads

    University of Cincinnati (UC) physicians are using a new technique that involves injecting patients with millions of tiny radioactive glass beads to control advanced, inoperable liver cancer.

    No wider than a single strand of human hair, the beads kill liver cancer cells from inside the tumor.


    Darryl Zuckerman, MD, offers the minimally invasive procedure, known as TheraSphere, at University Hospital and is the only physician in Ohio trained to perform it. UC’s Academic Health Center is one of 28 medical centers across the United States offering the treatment.


    “The only real cure for liver cancer is an organ transplant,” explains Zuckerman, an associate professor and interventional radiologist at UC. “But this procedure allows us to stabilize the patient’s condition by controlling cancer growth and shrinking the tumor. Then we can deal with it surgically, or as a stand-alone therapy for patients who aren’t good candidates for surgery.”


    This treatment is intended for patients with a form of cancer known as advanced hepatocellular carcinoma (HCC), which starts in the liver’s cells and develops into one or multiple tumors that cannot be removed in surgery.


    Primary liver cancer-which grows from within the organ as opposed to spreading there from another area of the body-is rare but is increasing at a very rapid rate in the United States, according to Zuckerman. HCC is the most common type of primary liver cancer in adults and accounts for 80 percent of all primary liver cancers. Colorectal, breast and gastric cancers also commonly spread to the liver.


    “By delivering highly targeted radiation from inside the body,” says Zuckerman, “we can help minimize damage to surrounding tissue and slow the progression of the liver cancer for patients awaiting liver transplant. For other patients, this procedure can reduce the size of the tumor to a point where it can be removed surgically, giving patients new hope for survival.”


    Two weeks before treatment patients undergo an angiogram, which allows an interventional radiologist to identify blood vessels feeding the liver tumor. Depending on the anatomy of the blood vessels, the radiologist may place metal coils in surrounding blood vessels to prevent the beads from traveling to other organs in the body.

    tropic of cancer

    Tropic of Cancer, parallel of latitude at 23°30' north of the equator; it is the northern boundary of the tropics. This parallel marks the farthest point north at which the sun can be seen directly overhead at noon; north of the parallel the sun appears less than 90° from the southern horizon at any day of the year. The sun reaches its vertical position over the Tropic of Cancer at about June 22, the summer solstice in the Northern Hemisphere. When the Tropic of Cancer was named, the sun was in the constellation Cancer at the time of the summer solstice.

    Where is it?

    All of us who have looked at a map have noticed a little dotted line called the Tropic of Cancer. In fact, here in Mazatlan, this little dotted is less than 15 miles north of us. But what is it, and what if anything does it have to do with Cancer? The answer is both simple and complicated. The simple answer is that the Tropic of Cancer is 23.5 degrees north latitude. So what? The real answer is a bit more complicated, and very interesting.

    Some History Back in the old days, before television, cellular phones, and the internet, people who had a lot of free time on their hands used to look up at the stars and the sky. They noticed a bunch of remarkable things. One of the things they noticed was that the sun and the stars did not appear in the same place at the same time every day. In the northern hemisphere, from winter until summer, the sun gradually rose higher and higher in the sky each day, while from the summer until winter, the opposite happened. By carefully measuring how high the sun rose at mid day, they discovered that around June 21 (in our current calendar, but that is another story) the sun got as high as it was ever going to get, and that around December 21 the sun stayer lower in the sky than on any other day. To make matters worse, how high and how low the sun gets depends on where you live. For the folks living near the equator, on June 21 the sun was up in the northern sky, their day was long and hot, but things cooled off at night, while for the folks living up near the north pole, the sun was to the south and moved in a small circle. In fact they were in the middle of 6 months of constant daylight. Something funny is clearly going on.

    endometrial cancer

    Endometrial cancer is one of the most common cancers in American women. In fact, about 40,000 American women receive a diagnosis of endometrial cancer each year, making it the fourth most common cancer found in women - after breast cancer, lung cancer and colon cancer.

    Endometrial cancer usually begins in the endometrium, the lining of the uterus - a hollow, pear-shaped pelvic organ where fetal development occurs. Endometrial cancer is most common after the reproductive years, between the ages of 60 and 70. Endometrial cancer is sometimes called uterine cancer, but there are other cells in the uterus that can become cancerous - such as muscle or myometrial cells. These form much less common cancers called sarcomas and account for less than 5 percent of uterine cancers.

    Endometrial cancer is often detected at an early stage because it frequently produces vaginal bleeding between menstrual periods or after menopause. If discovered early, this slow-growing cancer is likely to be confined to the uterus. Removing the uterus surgically often eliminates all of the cancer. In fact, stage I endometrial cancer is successfully treated more than 90 percent of the time. Unfortunately, not all endometrial cancer can be successfully treated. In these cases, the cancer has spread beyond the uterus by the time it's detected. About 7,000 American women die each year of endometrial cancer.

    testicular cancer symptom

    Testicular cancer

    Published by BUPA's Health Information Team

    February 2004

    Testicular cancer is a rare disease in men caused by abnormal growth of cells of the testicle. The testicles (or testes) are located inside the scrotum, the loose bag of skin that hangs below the penis. Each testicle (or testis) produces sperm.

    About testicular cancer

    Cancer of the testicles is not a common cancer overall, and is responsible for less than one per cent of all cancer deaths. However, it is the most common cancer in men aged 20 to 34. It is important for men to be aware of the disease so that they can recognise the symptoms. If caught early, testicular cancer can usually be treated and cured.

    Types of testicular cancer

    The most common types of testicular cancer are seminoma and teratoma. Seminomas are made up of a single type of cell, whereas teratomas consist of more than one type of testicular cell. Occasionally, the cancer can be a combination of seminoma and teratoma. Other types of testicular cancer, such as lymphoma, arise from lymphatic tissue (tissue that forms part of the immune system) within the testicle. These are very rare.

    What causes testicular cancer?

    The causes of testicular cancer are unknown, but men born with an undescended testicle (one that remains in the abdominal cavity rather than descending into the scrotum) may be at greater risk of developing the disease.

    Other factors that are thought to make testicular cancer more likely include:

  • having a brother who had testicular cancer

  • fertility problems

  • being from a wealthier social group

  • having a rare complication of mumps called mumps orchitis (painful swelling of the testis)

    Symptoms of testicular cancer

    The most common symptom of testicular cancer is a lump, irregularity or swelling in one testicle. Other symptoms that may be present are:

  • a pulling sensation or feeling of unusual heaviness in the scrotum

  • a dull ache in the groin or lower abdomen

  • pain or discomfort (which may come and go) in the testicle or scrotum

  • tenderness or enlargement of tissue in the breast area

  • a sudden collection of fluid in the scrotum (called a hydrocele).

    Most lumps in the scrotum are not testicular cancer. However, anyone who notices one or more of the symptoms above should see their GP for advice.

    Detecting testicular cancer

    Testicular cancer can't be prevented. To help detect it early, you should be aware of how your testicles feel normally, so that you notice any unusual lumps, irregularities, enlargements or areas of firmness.

    A good time to feel the testicles is when you are having a warm bath or shower, when the scrotal skin is relaxed. Feel each testicle by rolling it between thumb and forefinger.


    You may notice that one testicle is slightly larger than the other, which is normal. Also, it is normal to feel the epididymis - a small, firm, tube-like structure at the back of the testicle. This stores and transports sperm.

  • cancer treatment center of america

    Midway between Chicago and Milwaukee you'll find a special kind of hospital.

    Located in a restorative, rural setting in Zion, Illinois, Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center is one of the premier providers of cancer care in the world. We offer the best of traditional treatment-chemotherapy, radiation therapy and surgery-but go well beyond those disciplines to treat the whole person-not just the disease.

    Unlike other facilities that rely on a narrow spectrum of isolated treatments, CTCA constantly pushes the envelope to find the best combination of approved therapies for our patients' particular cancer. In fact, many of the nation's other leading cancer facilities are just beginning to embrace the whole-person approach we've been perfecting for the last 25 years.Our approach to care in Zion has attracted an internationally recognized team dedicated to eliminating cancer-many are professionals you just can't find at other hospitals. For instance, we have a female gynecologic oncologist on staff. Even though the National Institute of Health recommends women diagnosed with gynecologic cancers be treated by a specialist for optimal treatment outcome, most local and community hospitals do not have a gynecologic oncologist on staff.

    small cell lung cancer

    Alternative names

    Cancer - lung - small cell; Small cell lung cancer; SCLC

    Definition

    Small cell lung cancer (SCLC) is a fast-growing type of lung cancer. It tends to spread much more quickly than non-small cell lung cancer.

    There are three different types of small cell lung cancer:

  • Small cell carcinoma (oat cell cancer)

  • Mixed small cell/large cell carcinoma

  • Combined small cell carcinoma

    Most small cell lung cancers are the oat cell type.

    Causes, incidence, and risk factors

    About 15% of all lung cancer cases are small cell lung cancer, according to the American Cancer Society. Small cell lung cancer is a bit more common in men than women.

    Smoking almost always causes small cell lung cancer. This type of lung cancer is rare in those who have never smoked.

    Small cell lung cancer usually starts in the air tubes (bronchi) in the center of the chest. Although the cancer cells are small, they grow quickly and create large masses (tumors) that can rapidly spread to other parts of the body, including the brain, liver, and bone.

    Symptoms

  • Cough

  • Bloody sputum

  • Shortness of breath

  • Wheezing

  • Chest pain

  • Loss of appetite

  • Weight loss

    Additional symptoms that may be associated with this disease:

  • Weakness

  • Swallowing difficulty

  • Nail abnormalities

  • Hoarseness or changing voice

  • Fever

  • Facial swelling

    Signs and tests

    The health care provider will perform a physical exam and ask questions about your medical history. You will be asked if you smoke, and if so, how long you have smoked.

    When listening to the chest with a stethoscope, the health care provider can sometimes hear fluid around the lungs, which could (but doesn't always) suggest cancer.

    Small cell lung cancer has usually spread by the time it is diagnosed.

    Tests that may be performed include:

  • Chest x-ray

  • CBC

  • Sputum test

  • Bone scan

  • CT scan

  • MRI

  • Positron emission tomography (PET) scan

  • Thoracentesis <http://www.nlm.nih.gov/medlineplus/ency/article/003420.htm>

    In some cases, the health care provider may need to remove a piece of tissue from your lungs for examination under a microscope. This is called a biopsy. There are several ways to do this:

  • Bronchoscopy combined with biopsy

  • Pleural biopsy

  • CT scan directed needle biopsy

  • Mediastinoscopy with biopsy

  • Open lung biopsy

  • Endoscopic esophageal ultrasound (EUS) with biopsy

    Usually, if a biopsy reveals cancer, more imaging tests are done to find out the stage of the cancer. (Stage means how big the tumor is and how far it's spread.) However, the traditional staging system, which uses numbers to tell how bad the cancer is, is usually not used for patients with SCLC. Instead, SCLC is grouped as either:

  • Limited (cancer is only in the chest)

  • Extensive (cancer has spread outside the chest)


    Most cases are extensive.



  • sign of cancer

    What Are Symptoms and Signs? A symptom is an indication of disease, illness, injury, or that something is not right in the body. Symptoms are felt or noticed by a person, but may not easily be noticed by anyone else. For example, chills, weakness, achiness, shortness of breath, and a cough are possible symptoms of pneumonia. A sign is also an indication that something is not right in the body. But signs are defined as observations made by a doctor, nurse, or other health care professional. Fever, rapid breathing rate, and abnormal breathing sounds heard through a stethoscope are possible signs of pneumonia. The presence of one symptom or sign may not give enough information to suggest a cause. For example, a rash in a child could be a symptom of a number of things including poison ivy, an infectious disease like measles, an infection limited to the skin, or a food allergy. But if the rash is seen along with other signs and symptoms like a high fever, chills, achiness, and a sore throat, then a doctor can get a better picture of the illness. In many cases, a patient's signs and symptoms do not provide enough clues by themselves to determine the cause of an illness, and medical tests such as x-rays, blood tests, or a biopsy may be needed. How Does Cancer Produce Signs and Symptoms? Cancer is a group of diseases that may cause almost any sign or symptom. The signs and symptoms will depend on where the cancer is, the size of the cancer, and how much it affects the surrounding organs or structures. If a cancer spreads (metastasizes), then symptoms may appear in different parts of the body. As a cancer grows, it begins to push on nearby organs, blood vessels, and nerves. This pressure creates some of the signs and symptoms of cancer. If the cancer is in a critical area, such as certain parts of the brain, even the smallest tumor can produce early symptoms. Sometimes, however, cancers form in places where there may be no symptoms until the cancer has grown quite large. Pancreas cancers, for example, do not usually grow large enough to be felt from the outside of the body. Some pancreatic cancers do not produce symptoms until they begin to grow around nearby nerves, causing a backache. Others grow around the bile duct, which blocks the flow of bile and leads to a yellowing of the skin known as jaundice. By the time a pancreatic cancer causes these signs or symptoms, it has usually reached an advanced stage. A cancer may also cause symptoms such as fever, fatigue, or weight loss. This may be caused by cancer cells using up much of the body抯 energy supply or releasing substances that change the body抯 metabolism. Or the cancer may cause the immune system to react in ways that produce these symptoms. Sometimes, cancer cells release substances into the bloodstream that cause symptoms not usually thought to result from cancers. For example, some cancers of the pancreas can release substances which cause blood clots to develop in veins of the legs. Some lung cancers make hormone-like substances that affect blood calcium levels, affecting nerves and muscles and causing weakness and dizziness. How Are Signs and Symptoms Helpful? Treatment is most successful when cancer is found as early as possible. Finding cancer early usually means it can be treated while it is still small and is less likely to have spread to other parts of the body. This often means a better chance for a cure, especially if initial treatment is to be surgery. A good example of the importance of detecting cancer early is melanoma skin cancer. It is easily removed if it has not yet grown deeply into the skin, and the 5-year survival rate (percentage of people living at least 5 years after diagnosis) at this stage is nearly 100%. But once melanoma has spread to other parts of the body the survival rate drops dramatically. Sometimes people ignore symptoms either because they do not recognize the symptoms as being significant or because they are frightened by what they might mean and don抰 want to seek medical help. General symptoms, such as fatigue, are more likely to have a cause other than cancer and can seem unimportant, especially if they have an obvious cause or are only temporary. In a similar way, a person may reason that a more specific symptom like a breast mass is probably a cyst that will go away by itself. But neither of these symptoms should be discounted or overlooked, especially if they have been present for a long period of time or are getting worse. Most likely, any symptoms you may have will not be caused by cancer, but it抯 important to have them checked out by your doctor, just in case. If cancer is not the cause, your doctor can help figure out what is and treat it, if needed. In some cases it is possible to detect some cancers before symptoms occur. The American Cancer Society and other health groups encourage the early detection of certain cancers before symptoms occur by recommending a cancer-related checkup and specific tests for people who do not have any symptoms. For more information on early detection tests, see our document, "American Cancer Society Guidelines for the Early Detection of Cancer." Keep in mind, however, that these recommended tests do not diminish the importance of reporting any symptoms to your doctor. General Cancer Signs and Symptoms It is important to know what some of the general (non-specific) signs and symptoms of cancer are. They include unexplained weight loss, fever, fatigue, pain, and changes in the skin. Of course, it抯 important to remember that having any of these does not necessarily mean that cancer is present -- there are many other conditions that can cause these signs and symptoms as well. Unexplained weight loss: Most people with cancer will lose weight at some time with their disease. An unexplained (unintentional) weight loss of 10 pounds or more may be the first sign of cancer, particularly cancers of the pancreas, stomach, esophagus, or lung. Fever: Fever is very common with cancer, but is more often seen in advanced disease. Almost all patients with cancer will have fever at some time, particularly if the cancer or its treatment affects the immune system and reduces resistance to infection. Less often, fever may be an early sign of cancer, such as with leukemia or lymphoma. Fatigue: Fatigue may be a significant symptom as cancer progresses. It may occur early, however, in cancers such as with leukemia or if the cancer is causing a chronic loss of blood, as in some colon or stomach cancers. Pain: Pain may be an early symptom with some cancers, such as bone cancers or testicular cancer. Most often, however, pain is a symptom of advanced disease. Skin changes: In addition to cancers of the skin (see next section), some internal cancers can produce visible skin signs such as darkening (hyperpigmentation), yellowing (jaundice), reddening (erythema), itching, or excessive hair growth.

    breast cancer site

    Every year at this time, cancer doctors and researchers gather at the annual Breast Cancer Symposium in San Antonio, Texas, to hear the latest news in the field.

    This year we heard surprising news from investigators at M.D. Anderson: there was an overall 7 percent relative decline in diagnosed cases of breast cancer between 2002 and 2003. The number of breast cancer cases had increased in the 20 years before 2002.


    The steepest decline - 12 percent - occurred in women between ages 50 and 69 diagnosed with estrogen receptor positive (ER-positive) breast cancer. ER-positive breast cancer depends on hormones for tumor growth. One reason for the decline, according to the researchers, may be the 2002 announcement that hormone replacement therapy (HRT) is a major contributor to breast cancer growth. The announcement led thousands of women to stop taking these drugs.

    Although the researchers aren't 100 percent sure that stopping HRT is the only reason for the decline, Peter Ravin, Ph.D., the study's senior investigator, says "it makes perfect sense" if you consider that use of HRT may be an important contributing factor to breast cancer development. "Research has shown that ER-positive tumors will stop growing if they are deprived of the hormones, so it is possible that a significant decrease in breast cancer can be seen if so many women stopped using HRT," he says.

    We want everyone to help us raise funds for breast cancer research.

    There are many ways you can get involved, whether you fundraise for us by organising your own activity or buy merchandise.

    Register your interest now to find out about our sponsored walks taking place across the UK this Autumn.

    Together we will beat cancer.

    ABOUT THE BREAST CANCER SITE

    Your click on the "Fund Free Mammograms" button helps fund free mammograms, paid for by site sponsors whose ads appear after you click and provided to women in need through the efforts of the National Breast Cancer Foundation to low-income, inner-city and minority women, whose awareness of breast cancer and opportunity for help is often limited.

    EARLY DETECTION: DO YOU KNOW THE FACTS?


    This year in America, more than 211,000 women will be diagnosed with breast cancer and 43,300 will die. One woman in eight either has or will develop breast cancer in her lifetime. In addition, 1,600 men will be diagnosed with breast cancer and 400 will die this year. If detected early, the five-year survival rate exceeds 95%. Mammograms are among the best early detection methods, yet 13 million U.S. women 40 years of age or older have never had a mammogram.

    tongue cancer

    What is tongue cancer?

    There are two parts to your tongue, the oral tongue and the base of the tongue. Cancer can develop in either part. The oral tongue is the part you see when you ‘poke your tongue out’ at someone. This is the front two thirds of your tongue. Cancers that develop in this part of the tongue come under a group of cancers called mouth (oral) cancer.


    The base of the tongue is the back third of the tongue. This part is very near your throat (pharynx). Cancers that develop in this part are called oropharyngeal cancers (pronounced oar-o-farin-gee-al).

    Types of tongue cancer

    The most common type of tongue cancer is squamous cell carcinoma (SCCA). Squamous cells are the flat, skin-like cells that cover the lining of the mouth, nose, larynx, thyroid and throat. Squamous cell carcinoma is the name given to a cancer that starts in these cells.

    Symptoms


    The symptoms of tongue cancer may include



  • A red or white patch on the tongue, that will not go away

  • A sore throat that does not go away

  • A sore spot on the tongue that does not go away

  • Pain when swallowing

  • Numbness in the mouth that will not go away

  • Unexplained bleeding from the tongue (that is, not caused by biting your tongue or other injury)

  • Pain in the ear (rare)

    Do bear in mind that these symptoms may be due to a less serious medical condition. But it is important to check symptoms with your GP just to make sure




  • liver cancer symptom

    Liver cancer is sometimes called a "silent disease" because in an early stage it often does not cause symptoms. But, as the cancer grows, symptoms may include:

    Pain in the upper abdomen on the right side; the pain may extend to the back and shoulder

    Swollen abdomen (bloating)

    Weight loss

    Loss of appetite and feelings of fullness

    Weakness or feeling very tired

    Nausea and vomiting

    Yellow skin and eyes, and dark urine from jaundice

    Fever

    Some of the possible causes of Liver cancer are included in the list below:

    Other cancers - liver cancer is a common metastasis

    Breast cancer

    Colon cancer

    Lung cancer

    Stomach cancer

    See full list of 16 causes of Liver cancer

    Detailed information about the causes of Liver cancer including medication causes and drug interaction causes can be found in our causes pages.

    With a diagnosis of Liver cancer, it is also important to consider whether there is an underlying condition causing Liver cancer. Underlying medical conditions are other medical conditions that may possibly cause Liver cancer.

    Treatments for Liver cancer include:

    Chemotherapy

    Hepatic arterial infusion

    Hepatic arterial infusion pump

    Chemoembolization

    Radiation therapy

    rectal cancer

    Definition of colon cancer: Cancer that forms in the tissues of the colon (the longest part of the large intestine). Most colon cancers are adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids).



    Definition of rectal cancer: Cancer that forms in the tissues of the rectum (the last several inches of the large intestine before the anus).



    Estimated new cases and deaths from colon and rectal cancer in the United States in 2007:





    New cases: 112,340 (colon); 41,420 (rectal)



    Deaths: 52,180 (colon and rectal combined)

    Prognostic factors

    The prognosis of patients with colon cancer is clearly related to the degree of penetration of the tumor through the bowel wall, the presence or absence of nodal involvement, and the presence or absence of distant metastases. These 3 characteristics form the basis for all staging systems developed for this disease. Bowel obstruction and bowel perforation are indicators of poor prognosis. Elevated pretreatment serum levels of carcinoembryonic antigen (CEA) have a negative prognostic significance. The American Joint Committee on Cancer and a National Cancer Institute-sponsored panel recommended that at least 12 lymph nodes be examined in patients with colon and rectal cancer to confirm the absence of nodal involvement by tumor. This recommendation takes into consideration that the number of lymph nodes examined is a reflection of the aggressiveness of lymphovascular mesenteric dissection at the time of surgical resection and the pathologic identification of nodes in the specimen. Retrospective studies demonstrated that the number of lymph nodes examined in colon and rectal surgery may be associated with patient outcome.Many other prognostic markers have been evaluated retrospectively for patients with colon cancer, though most, including allelic loss of chromosome 18q or thymidylate synthase expression_, have not been prospectively validated. Microsatellite instability, also associated with hereditary nonpolyposis colon cancer (HNPCC), has been associated with improved survival independent of tumor stage in a population-based series of 607 patients younger than 50 years with colorectal cancer. Treatment decisions depend on factors such as physician and patient preferences and the stage of the disease rather than the age of the patient. Racial differences in overall survival after adjuvant therapy have been observed, without differences in disease-free survival, suggesting that comorbid conditions play a role in survival outcome in different patient populations.

    rectal cancer

    Definition of colon cancer: Cancer that forms in the tissues of the colon (the longest part of the large intestine). Most colon cancers are adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids).



    Definition of rectal cancer: Cancer that forms in the tissues of the rectum (the last several inches of the large intestine before the anus).



    Estimated new cases and deaths from colon and rectal cancer in the United States in 2007:





    New cases: 112,340 (colon); 41,420 (rectal)



    Deaths: 52,180 (colon and rectal combined)

    Prognostic factors

    The prognosis of patients with colon cancer is clearly related to the degree of penetration of the tumor through the bowel wall, the presence or absence of nodal involvement, and the presence or absence of distant metastases. These 3 characteristics form the basis for all staging systems developed for this disease. Bowel obstruction and bowel perforation are indicators of poor prognosis. Elevated pretreatment serum levels of carcinoembryonic antigen (CEA) have a negative prognostic significance. The American Joint Committee on Cancer and a National Cancer Institute-sponsored panel recommended that at least 12 lymph nodes be examined in patients with colon and rectal cancer to confirm the absence of nodal involvement by tumor. This recommendation takes into consideration that the number of lymph nodes examined is a reflection of the aggressiveness of lymphovascular mesenteric dissection at the time of surgical resection and the pathologic identification of nodes in the specimen. Retrospective studies demonstrated that the number of lymph nodes examined in colon and rectal surgery may be associated with patient outcome.Many other prognostic markers have been evaluated retrospectively for patients with colon cancer, though most, including allelic loss of chromosome 18q or thymidylate synthase expression_, have not been prospectively validated. Microsatellite instability, also associated with hereditary nonpolyposis colon cancer (HNPCC), has been associated with improved survival independent of tumor stage in a population-based series of 607 patients younger than 50 years with colorectal cancer. Treatment decisions depend on factors such as physician and patient preferences and the stage of the disease rather than the age of the patient. Racial differences in overall survival after adjuvant therapy have been observed, without differences in disease-free survival, suggesting that comorbid conditions play a role in survival outcome in different patient populations.

    sign of breast cancer

    Breast cancer is the most common malignancy in women and the second leading cause of cancer death (exceeded by lung cancer in 1985). Breast cancer is three times more common than all gynecologic malignancies put together. The incidence of breast cancer has been increasing steadily from an incidence of 1:20 in 1960 to 1:7 women today.

    The American Cancer Society estimates that 211,000 new cases of invasive breast cancer will be diagnosed this year and 43,300 patients will die from the disease. Breast cancer is truly an epidemic among women and we don't know why.

    Breast cancer is not exclusively a disease of women. For every 100 women with breast cancer, 1 male will develop the disease. The American Cancer society estimates that 1,600 men will develop the disease this year. The evaluation of men with breast masses is similar to that in women, including mammography.

    The incidence of breast cancer is very low in the twenties (age) gradually increases and plateaus at the age of forty-five and increases dramatically after fifty. Fifty percent of breast cancer is diagnosed in women over sixty-five indicating the ongoing necessity of yearly screening throughout a woman's life.

    Breast cancer is considered a heterogenous disease, meaning that it is a different disease in different women, a different disease in different age groups and has different cell populations within the tumor itself. Generally, breast cancer is a much more aggressive disease in younger women. Autopsy studies show that 2% of the population has undiagnosed breast cancer at the time of death. Older women typically have much less aggressive disease than younger women.

    cancer farrah fawcett

    Like any cancer, the exact reason why one person gets esophagus cancer and another does not remainsunknown. However, various "risk factors" have been noted to increase the risk for developing esophagus cancer.



    People don't think much about their esophagus (food tube) unless it gets diseased. Esophagus cancer used to be uniformly fatal, but newer treatments offer more hope of survival and comfort than ever before.

    It is critical to get the right treatment for esophagus cancer- this can literally make the difference between life and death. Understanding your choices gives you the peace-of-mind of knowing that you have done everything possible to fight esophagus cancer successfully.

    CancerAnswers's material explains, in plain English, the definition, types, frequency, symptoms, evaluation, historic treatment and latest effective treatment for esophagus cancer. We describe surgery, radiation and chemotherapy, and tell you their results. We tell you everything you need to know to make the right choices today to deal with an esophagus cancer problem. This is just an excerpt of CancerAnswers's report on esophagus cancer. Much more, including latest can be sent to you by mail when you order at a nominal cost. Thank you for using CancerAnswers as your information resource.

    anal cancer

    There were12,500 new cases of esophagus cancer and 11,000 deaths attribute-

    bale to the disease in 1996. It Accounts for 5% of Gastrointestinal cancers and about 1% of all new cancers in the U.S.A. The overall number of cases each year is steadily increasing. In some places, like Northern China, it is 10 times more common than in North America. It is the 7th most common cancer worldwide. In the U.S.A. men are affected more than twice as commonly as women, and Black men 3 times as often as White men. The average patient is 60 years old.The most common type had always been "squamous cell carcinoma" arising from

    the upper 2/3 of the esophagus. Now, however, there has been a dramatic increase in another type, called "adenocarcinoma", which tends to arise in the lower 1/3 of the esophagus. Currently, the number of each of these two types of cancer cases is about equal, and together they make up nearly 100% of today's esophagus cancers. White men tend to get the disease more commonly in the lower esophagus, while Black men get it in the middle and upper esophagus.



    There are occasional rare cancers found in the esophagus, such as "sarcomas" which arise from the muscular wall, "cylindroma" which begins from glands, and "lymphoma" that starts from the body's immune system cells within the esophagus.

    cancer cure

    The esophagus, like all body tissues, is made up of individual cells. Normally, cells within the forming esophagus divide and grow very rapidly in the womb, in early childhood, and through puberty. In adulthood, new cells are only formed to replace those which have died from injury, old age or disease. The division of cells to produce new ones is under tight control by the "genes" within each cell. These genes are made up of DNA, and if it becomes damaged, the cell may start dividing out of control.Esophagus cancer starts in a single cell which has become abnormal. This cells produces millions, and eventually billions, of copies of itself. The copies are called"clones". These clones fail to function as normal esophagus tissue, but instead divert resources from healthy cells to fuel their own growth. When there are about 1 billion cells, they form a clump, or "tumor" 1/2 inch across. A "tumor" merely means a swelling, it can be caused by infection, inflammation, cancer or whatever. If a tumor only grows in it's local area (even very large) but does not have the capacity to spread to distant body areas, it is called"benign" and isnot cancer. If, however, the tumor has the ability to spread to distant body areas, it is called "malignant" andthis is cancer. The actual process of spread is called"metastasis", and can occur to any area of the body.



    The most common type of benign esophageal tumor arises from the muscular layer, and is called a "leiomyoma". Unfortunately, a quickly growing tumor within the esophagus is most likely to be cancerous.

    pancreatic cancer symptom

    The esophagus has an outer lining, called the "adventitia", which surrounds the muscular layers and separates the esophagus from other nearby organs. The heart is directly behind the middle esophagus, while the windpipe ("trachea") is directly in front of it. The esophagus is also very close to the liver, lungs, and major blood vessels from the heart ("aorta and venal cava"). The esophagus receives most of it's blood from the aorta and drains it to the liver and venal cava. A system of "drainage channels" runs through the esophagus, between the mucosal and muscular layers. These are called "lymph channels" and act to purify the blood serum, by transporting it to nearby "lymph nodes" (glands) where the serum is filtered. Both the blood supply, and lymph channels and glands, can act as conduits to spread infection or cancer. This spread may be along the length of the esophagus, around it's diameter, to local lymph nodes or organs, or to distant body areas.

    When a person has shrinkage ("cirrhosis") of the liver due to excessive alcohol or chronic infections, it places back pressure on the blood draining from the esophagus. This results in swelling of the blood vessels in the lower esophagus, called "varices". These may spontaneously bleed when there is a lot a pressure between the liver and esophagus ("portal hypertension") and is a medical emergency. Other common problems with the esophagus (besides cancer) are "rings" or "webs"-- areas of protrusion into the normally hollow interior ("lumen") of the esophagus where food can get caught. A "stricture" is an area of narrowing of the esophagus, often from scarring from ingested chemicals (i.e. lye). Achalasia is a disease where the nerves in the esophagus don't coordinate swallowing properly, so food gets caught there. An inflammation is "esophagitis", caused by bacteria, virus, or fungi, drugs or radiation.

    esophagus cancer

    The wall of the esophagus has several layers. Cancer of the esophagus -- also referred to as esophageal cancer ... People with Barrett esophagus are at a highly increased risk for developing cancer of the esophagus (estimated at 30-100 ...

    Esophageal cancer is a disease where malignant (cancerous) cells arise in the tissues of the esophagus. ... There are two main types of esophageal cancer (depending on how the cells appear under the microscope); approximately half are ...

    The esophagus (UK spelling: oesophagus) is a long hollow muscular tube which connects the throat to the stomach. Esophageal cancer is a disease where malignant (cancerous) cells arise in the tissues of the esophagus. The most common symptom is difficulty in swallowing. It can also be associated with weight loss and sometimes pain or discomfort behind the breast bone or in the back - these symptoms should be checked by a doctor but not are sure signs of cancer. There are two main types of esophageal cancer (depending on how the cells appear under the microscope); approximately half are classed as "squamous cell carcinomas" and half as "adenocarcinomas". People with frequent gastric reflux leading to barrest’s have an increased risk of developing esophageal cancer.

    The esophagus is a hollow tube that transfers food from the throat to the stomach, that is the "food tube". The tube starts just below the "epiglottis", the flap that keeps food from going into our trachea (air pipe) when we swallow. It ends at where it joins with the upper portion of the stomach, called the "cardia". The actual area of coinage is called the "gastroesophageal junction". The esophagus is muscular, to help propel food downward with swallowing. It has a complex array of nerves ("plexus") that work to coordinate the swallowing motion. The upper 2/3 of the esophagus has a inner lining ("mucosa") of a special type of cell, called "squamous" cells, which are also found in the mouth and anal region. These cells resist abrasion and heat and are able to heal quickly if damaged, say by the sharp edges on food. The lower 1/3 of the esophagus has an inner lining of a different type of mucosa called "columnar" cells.



    This becomes important for considering the cancers that arise in the esophagus. If the lower portion of the esophagus becomes infiltrated with intestinal-like glands, as it is prone to do with prolonged irritation, then this is called "Barrett's" esophagus and is a risk factor to get cancer, as will be seen.

    colorectal cancer

    Colon cancer is cancer that starts in the large intestine (colon) or the rectum (end of the colon). Such cancer is sometimes referred to as "colorectal cancer."

    Other types of colon cancer such as lymphoma,carcinoid tumors, melonema, and sarcomas are rare. In this article, use of the term "colon cancer" refers to colon carcinoma and not these rare types of colon cancer.

    Causes, incidence, and risk factors

    According to the American Cancer Society, colorectal cancer is one of the leading causes of cancer-related deaths in the United States. (However, in almost all cases, early diagnosis can lead to a complete cure.)

    There is no single cause for colon cancer. Nearly all colon cancers begin as benign polyps, which slowly develop into cancer

    Certain genetic syndromes also increase the risk of developing colon cancer.What you eat may play a role in your risk of colon cancer. Colon cancer may be associated with a hight-fat, low-fiber diet and red meat. However, some studies found that the risk does not drop if you switch to a high-fiber diet, so the cause of the link is not yet clear

    lung cancer treatment

    As is true of many cancers, the treatment of lung cancer depends upon a variety of factors. The most important factors are the histopathologic (diseased tissue) type of tumor that is present and its stage. Once a lung cancer has been staged, the physician and patient can discuss treatment options. An individual then has a better idea of the value of different forms of therapy. Other factors that are taken into account include the person's general health, medical problems that may affect treatment (such as chemotherapy), and tumor characteristics.

    The characteristics of the lung tumor help to separate individuals into two groups: (1) those who are at low risk of cancer recurrence and (2) those who are at high risk of cancer recurrence. Specific prognostic - disease-forecasting - factors place patients in either of these groups. In particular, the histopathologic groupings of small cell lung carcinoma (SCLC) versus non-small cell lung carcinoma (NSCLC) may be used to better predict a patient's prognosis and response to therapy.

    Surgical resection, or cutting away, of the tumor generally is indicated for disease that has not spread beyond the lung. Such resection may be conducted using a variety of techniques. Thoracotomy - the opening of the chest wall for surgical procedures - and median sternotomy - surgery performed by cutting through the breastbone - are standard methods used for lung cancer surgery. Alternative approaches include anterior limited thoractomy (ALT), thoractomy performed on the frontal chest using a small incision; anterioraxillary thoracotomy (AAT), thoracotomy performed on the frontal chest near the underarm), and posterolateral thoracotomy (PLT) thoracotomy performed on the back/side region of the trunk. ALT, in particular, is less invasive than standard thoractomy - that is, it involves less disturbance of the body by incisions or other intrusive measures. ALT may result in less surgical blood loss, less postoperative drainage, and less postoperative pain than standard thoracotomy.

    Recently, surgeons have developed other less invasive procedures for the removal of tumorous tissue. For example, video-assisted thoracoscopy (VAT), otherwise known as video-assisted thoracic surgery (VATS), uses a video camera to help visualize and operate upon the lung within the chest cavity. The surgical incisions made during VAT are much smaller than those needed for thoracotomy or sternotomy. However, some physicians caution that VAT does not allow complete lung examination to identify and remove metastases that are not detected by preoperative chest X-ray. VAT is perhaps most appropriate for Stage 1 and Stage 2 cancers that require lobectomy (surgical removal of a lung lobule) with lymphadenectomy (removal of one or more lymph nodes) and for peripheral (outer edge) lung tumors that can be removed by wedge resection. In such cases, follow-up is required to establish a long-term prognosis.

    Computed tomography (CT) scans also have been added to VAT technology to improve lung cancer surgery. Experts have found that percutaneous (through the skin) CT-guided localization wires help to identify tumorous lung nodules. In this way, wires can be used to assist VAT in cases that need sublobectomy resection (partial removal of a lung lobe).

    Unfortunately, surgical procedures may cause lymphocytopenia - low number of lymphocytes (white blood cells) in the blood - which is linked with shorter survival times among patients with advanced lung cancer. Lymphocytopenia may be related to a deficiency in interleukin-2 (IL-2), a hormone that controls the activity of T lymphocytes (thymus-dependent lymphocytes). Preoperative treatment with recombinant human interleukin-2 (rhIL-2) may help to prevent the lymphocyte decrease that occurs after surgery for operable lung cancer.

    If the tumor is more aggressive and/or widespread, chemotherapy and radiotherapy (radiation therapy) also may be necessary. In addition to chemotherapy and radiotherapy, other treatments are now available for the management of lung cancer.

    Photodynamic therapy (PDT) may be especially useful for the care of persons with inoperable lung cancer. Photodynamic therapy begins with the injection of a light-activated drug (e.g., photofrin/polyhaematoporphyrin, lumin). Then, during bronchoscopy (examination of the airways using a flexible scope), the lung tumor is illuminated by a laser fiber that transmits light of a specific wavelength. At that time, the laser light is used to destroy the sensitized tumor tissue. Skin photosensitivity (light sensitivity) is a side effect of PDT. The curative potential of PDT is the most exciting aspect of this therapy in lung cancer patients whose tumors are occult (hidden, unseen) on chest X-ray. The tissue-sparing effects of PDT may be particularly important for individuals with limited lung function.

    Electrosurgery

    · A lump is detected, which is usually single, firm, and most often painless.

    · A portion of the skin on the breast or underarm swells and has an unusual appearance.

    · Veins on the skin surface become more prominent on one breast.

    · The breast nipple becomes inverted, develops a rash, changes in skin texture, or has a discharge other than breast milk.

    · A depression is found in an area of the breast surface.

    Women's breasts can develop some degree of lumpiness, but only a small percentage of lumps are malignant.

    While a history of breast cancer in the family may lead to increased risk, most breast cancers are diagnosed in women with no family history. If you have a family history of breast cancer, this should be discussed with your doctor.